Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019.

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019. Clin Cancer Res. 2015 Jun 15; 21(12):2771-9.

View in: PubMed

subject areas

Adult
Aged
Albumins
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Biomarkers, Tumor
Cell Count
Female
Humans
Middle Aged
Neoplasm Metastasis
Neoplastic Cells, Circulating
Paclitaxel
Prognosis
Triple Negative Breast Neoplasms

authors with profiles

Rita Nanda